TCL Archive Also in this 8-page issue: Cooperative groups tell Congress that NCI’s $115 million in support for adult cancer clinical trials is “chump change.” Trials would close faster, report results sooner, if funding were increased, regulatory issues streamlined. May 28, 2004
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive In Brief: Hatch To Speak At AACI Dinner; NIH Plans 1987 Centennial; Cox To Head Columbia Radiotherapy May 24, 1985
